P. Warde

发表

Intra-prostatic fiducial markers and concurrent androgen deprivation.

A. Nichol, T. Rosewall, C. Catton, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers.

K. Brock, G. Lockwood, A. Nichol, 2007, International journal of radiation oncology, biology, physics.

The inclusion of capillary distribution in the adiabatic tissue homogeneity model of blood flow.

T S Koh, J Darko, M. Haider, 2001, Physics in medicine and biology.

Interobserver variation in prostate cancer Gleason scoring: are there implications for the design of clinical trials and treatment strategies?

J. Srigley, P. Warde, M. Mclean, 1997, Clinical oncology (Royal College of Radiologists (Great Britain)).

A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer.

G. Lockwood, P. Warde, J. Waldron, 2001, International journal of radiation oncology, biology, physics.

Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate.

T. Rosewall, C. Catton, D. Jaffray, 2007, International journal of radiation oncology, biology, physics.

Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and urethrography.

C. Catton, P. Warde, M. Mclean, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer.

G. Lockwood, T. Rosewall, C. Catton, 2007, International journal of radiation oncology, biology, physics.

A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.

A. Garden, K. Ang, M. Chambers, 2004, International journal of radiation oncology, biology, physics.

Clinical application of high-dose, image-guided intensity-modulated radiotherapy in high-risk prostate cancer.

C. Ménard, R. Bristow, T. Rosewall, 2010, International journal of radiation oncology, biology, physics.

Accuracy and sensitivity of finite element model-based deformable registration of the prostate.

David A Jaffray, Cynthia Ménard, Kristy K Brock, 2008, Medical physics.

Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers.

T Haycocks, H Alasti, C. Catton, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response.

C. Ménard, C. Parker, C. Catton, 2007, Cancer research.

Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy.

Masoom A Haider, Vickie Kong, Cynthia Ménard, 2007, International journal of radiation oncology, biology, physics.

A survey of radiation treatment planning peer-review activities in a provincial radiation oncology programme: current practice and future directions

Michael Sharpe, Sophie Foxcroft, P. Warde, 2013, BMJ Open.

Portal imaging for evaluation of daily on-line setup errors and off-line organ motion during conformal irradiation of carcinoma of the prostate.

H Alasti, C. Catton, P. Warde, 2001, International journal of radiation oncology, biology, physics.

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

Jacques Bernier, Michel Bolla, Laurence Collette, 2002, The Lancet.

Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor.

P. Warde, Philippe Bédard, A. Hansen, 2020, European urology oncology.

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer

P. Warde, Philippe Bédard, J. Lewin, 2020, Current oncology.

Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapy.

C. Ménard, R. Bristow, C. Catton, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The management of high-risk, locally advanced, prostate cancer radiation therapy.

P. Warde, S. Sridharan, 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Intensity-modulated radiotherapy in the treatment of prostate cancer.

P. Warde, G. Bauman, R. B. Rumble, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.

C. Ménard, R. Bristow, G. Lockwood, 2011, International journal of radiation oncology, biology, physics.

Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer.

L. Jacks, C. Ménard, R. Bristow, 2012, International journal of radiation oncology, biology, physics.

A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma

A. Bezjak, P. Warde, M. Gospodarowicz, 2005, Cancer.

A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy versus Two Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer.

Kelvin K. W. Chan, P. Warde, D. D'Souza, 2020, International Journal of Radiation Oncology, Biology, Physics.

Impact of androgen deprivation therapy on cardiovascular disease and diabetes.

P. Warde, A. Cheung, N. Fleshner, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carcinoma-in-situ of the glottic larynx: results of treatment with radiation therapy.

Fei Liu, P. Warde, J. Waldron, 2001, International journal of radiation oncology, biology, physics.

Robotic retroperitoneal lymph node dissection for primary and post-chemotherapy testis cancer

P. Warde, A. Hansen, P. Chung, 2021, Journal of Robotic Surgery.

Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill

R. Bristow, P. Warde, P Warde, 2003, Prostate Cancer and Prostatic Diseases.

Comparison of implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate

C. Catton, D. Jaffray, P. Warde, 2004 .

Management of decreased bone mineral density in men starting androgen‐deprivation therapy for prostate cancer

I. Tannock, G. Naglie, G. Tomlinson, 2009, BJU international.

Carcinoma of the prostate: case report.

P. Warde, M. Gospodarowicz, 1993, Canadian journal of surgery. Journal canadien de chirurgie.

Bladder cancer: long-term follow-up results of patients treated with radical radiation.

P. Warde, M. Gospodarowicz, B. Cummings, 1991, Clinical oncology (Royal College of Radiologists (Great Britain)).

Healthcare costs associated with prostate cancer: estimates from a population‐based study

G. Naglie, G. Tomlinson, P. Warde, 2010, BJU international.

"I sleep better at night:" How peer review of radiation treatment plans indirectly improves quality of care across radiation treatment programs.

P. Warde, M. Brundage, E. Gutierrez, 2017, Practical radiation oncology.

Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular Cancer.

P. Warde, Philippe Bédard, A. Hansen, 2017, European urology.

Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy

P. Warde, T. Panzarella, M. Gospodarowicz, 2013, BJU international.

Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial.

Bingshu E. Chen, M. Parmar, M. Sydes, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I pilot study of preoperative radiotherapy for prostate cancer: Long-term toxicity and oncologic outcomes.

T. H. van der Kwast, R. Bristow, T. Rosewall, 2019, Journal of Clinical Oncology.

Management and outcome of glottic cancer : A population-based comparison between Ontario, Canada and the SEER areas of the United States

P. Warde, B. O'Sullivan, W. Mackillop, 2000 .

Improving Quality of Radiation Therapy Care Across Ontario using a Community-of-Practice Approach.

P. Warde, E. Gutierrez, J. Gilbert, 2019, Practical radiation oncology.

Surveillance for stage I testicular seminoma. Is it a good option?

P. Warde, M. Jewett, M. A. Jewett, 1998, The Urologic clinics of North America.

Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancer.

C. Ménard, C. Catton, P. Warde, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The effect of bowel preparation regime on interfraction rectal filling variation during image guided radiotherapy for prostate cancer

R. Bristow, T. Rosewall, C. Catton, 2017, Radiation oncology.

Image guided dose escalated prostate radiotherapy: still room to improve

C. Ménard, T. Rosewall, C. Catton, 2009, Radiation oncology.

Image guided dose escalated prostate radiotherapy: still room to improve

C. Ménard, T. Rosewall, C. Catton, 2009, Radiation Oncology (London, England).

A dose-volume histogram analysis of the seminal vesicles in men treated with conformal radiotherapy to 'prostate alone'.

C. Parker, C. Catton, P. Warde, 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy.

T. H. van der Kwast, L. Collette, R. Mirimanoff, 2012, European journal of cancer.

The impact of irregularly rising prostate-specific antigen and "impending failure" on the apparent outcome of localized prostate cancer following radiotherapy.

C. Catton, P. Warde, M. Gospodarowicz, 2001, International journal of radiation oncology, biology, physics.

Testicular seminoma: Scattered radiation dose to the contralateral testis in the modern era.

P. Warde, P. Chung, T. Craig, 2018, Practical radiation oncology.

Electronic surveillance of testicular cancer: understanding patient perspectives on access to electronic medical records.

Joanne E. Eakin, P. Warde, M. Jewett, 2009, Journal of oncology practice.

Improving bone health in men with prostate cancer receiving androgen deprivation therapy: Results of a randomized phase 2 trial

G. Tomlinson, P. Warde, J. Jones, 2018, Cancer.

Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of life.

C. Ménard, C. Catton, P. Warde, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Testicular cancer survivors' supportive care needs and use of online support: a cross-sectional survey

J. L. Bender, P. Warde, M. Gospodarowicz, 2012, Supportive Care in Cancer.

Management of stage I testicular cancer

P. Warde, R. Hamilton, R. Clark, 2021, Current opinion in urology.

Practical and clinical applications of radiation therapy

P. Warde, J. Skliarenko, 2016 .

Radiotherapy: practical applications and clinical aspects

P. Warde, 2004 .

Assessment of palliative response in hyperthermia.

O. S. Nielsen, P. Warde, A. Munro, 1992, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Treatment Options, Prognostic Factors and Selection of Treatment in Stage I Seminoma

P. Warde, P. Chung, Jarad Martin, 2006, Oncology Research and Treatment.

Intergroup randomized phase III study of androgen deprivation therapy (ADT) plus radiation therapy (RT) in locally advanced prostate cancer (CaP) (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110; NCT00002633).

M. Sydes, P. Warde, K. Ding, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

patho-Treatment-related toxicity and symptom-related bother following postoperative radiotherapy for prostate cancer

Bristow, C. Ménard, C. Catton, 2010 .

Information needs of men on androgen deprivation therapy

P. Warde, N. Fleshner, S. Alibhai, 2010, BJU international.

Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting.

P. Warde, T. Pickles, G. Morton, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Carcinoma of the prostate: results of radical radiotherapy (1970-1985).

C. Catton, P. Warde, M. Gospodarowicz, 1993, International journal of radiation oncology, biology, physics.

Recommendations for followup of stage I and II seminoma: The Princess Margaret Cancer Centre approach.

P. Warde, Philippe Bédard, A. Hansen, 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Clinical dilemmas in local and regional testis cancer.

R. Huddart, P. Albers, P. Warde, 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Portal film analysis of an escalated dose conformal prostatic irradiation protocol using fiducial markers and portal images to confirm target organ and isocentre position

C. Catton, P. Warde, H. Alasti, 1998 .

The prognostic significance of the tumour infiltrating lymphocyte count in stage I testicular seminoma managed by surveillance.

C. Parker, C. Catton, P. Warde, 2002, European journal of cancer.

Local Failure in High-grade Prostate Cancer: An Elusive but Important Outcome and Target for Clinical Trials.

P. Warde, S. Alibhai, 2019, European urology.

127Immediate hormonal therapy improves locoregional control and survival in patients with locally advanced prostate cancer. Results of a randomized phase III clinical trial of the eortc radiotherapy and genito-urinary tract cancer cooperative groups

M. Piérart, R. Mirimanoff, P. Warde, 1996 .

The Capital Investment Strategy for Radiation therapy in Ontario: A Framework to Ensure Access to Radiation Therapy

P. Warde, M. Brundage, K. Malkoske, 2019, Advances in radiation oncology.

Progression detection of stage I nonseminomatous testis cancer on surveillance: implications for the followup protocol.

C. Catton, P. Warde, M. Gospodarowicz, 1999, The Journal of urology.

Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration‐resistant prostate cancer treated with Radium‐223

C. Catton, P. Warde, A. Zlotta, 2021, Cancer medicine.

Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.

I. Tannock, R. Bristow, C. Catton, 2007, Urologic oncology.

Original article Long-term outcome of radiation-based conservation therapy for invasive bladder cancer

I. Tannock, R. Bristow, C. Catton, 2007 .

The role of radiation therapy in the management of transitional cell carcinoma of the bladder.

P. Warde, M. Gospodarowicz, 1992, Hematology/oncology clinics of North America.

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

S. Fosså, S. Culine, A. Horwich, 2008, European urology.

Discrepancy in pathology reports upon second review of radical orchiectomy specimens for testicular germ cell tumors.

P. Warde, L. Landoni, M. Jewett, 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Salvage radiotherapy for PSA failure after radical prostatectomy.

C. Parker, C. Catton, P. Warde, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic

P. Warde, L. Rabeneck, D. Langer, 2022, JAMA network open.

Prostate cancer radiotherapy 2002: the way forward.

C. Catton, P. Warde, T. Pickles, 2005, The Canadian journal of urology.

Hypofractionated intensity modulated radiation therapy for prostate cancer

R. Bristow, C. Catton, P. Warde, 2002 .

New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder

P. Warde, M. Gospodarowicz, 1997, World Journal of Urology.

Survey of radiation oncologists: practice patterns of the management of stage I seminoma of testis in Canada and a selected group in the United States.

P. Warde, H. Sandler, G. Deboer, 2002, The Canadian journal of urology.

Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.

P. Warde, Philippe Bédard, P. Chung, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Canadian consensus guidelines for the management of testicular germ cell cancer.

R. Huddart, P. Albers, P. Warde, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Results of a policy of surveillance in stage I testicular seminoma.

P. Goodman, C. Catton, P. Warde, 1993, International journal of radiation oncology, biology, physics.

Utility of serum tumor markers during surveillance for stage I seminoma

P. Warde, T. Panzarella, M. Gospodarowicz, 2012, Cancer.

T1/T2 GLOTTIC CANCER MANAGED BY EXTERNAL BEAM RADIOTHERAPY: THE INFLUENCE OF PRETREATMENT HEMOGLOBIN ON LOCAL CONTROL

R. Bristow, P. Warde, J. Waldron, 1998 .

Intergroup Randomized Phase 3 Study of Androgen Deprivation Therapy (ADT) plus Radiation Therapy (RT) in Locally Advanced Prostate Cancer (CaP) (NCIC-CTG, SWOG, MRC-UK, and INT: T94-0110; NCT00002633)

M. Sydes, P. Warde, K. Ding, 2010 .

Active surveillance is the preferred approach to clinical stage I testicular cancer.

T. Powles, P. Albers, C. Bokemeyer, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surveillance in stage I testicular seminoma - risk of late relapse.

C. Parker, C. Catton, P. Warde, 2002, The Canadian journal of urology.

Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.

A. Horwich, P. Warde, L. Specht, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Management of localized seminoma, stage I-II: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.

S. Fosså, R. Huddart, P. Warde, 2011, Urology.

No role for routine chest radiography in stage I seminoma surveillance.

P. Warde, T. Panzarella, M. Gospodarowicz, 2010, European urology.

Are carboplatin and radiotherapy equally effective for the adjuvant treatment of stage I seminoma?

P. Warde, 2006, Nature Clinical Practice Oncology.

A Canadian approach to the regionalization of testis cancer: A review.

R. Huddart, P. Albers, P. Warde, 2019, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

CUAJ – Review Nason et al Regionalization of testis cancer

R. Huddart, P. Albers, P. Warde, 2020 .

Controversies in the management of clinical stage 1 testis cancer.

R. Huddart, P. Albers, P. Warde, 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance

P. Warde, S. Tyldesley, T. Panzarella, 2014, Cancer medicine.

Stage I seminoma: adjuvant treatment is effective but is it necessary?

P. Warde, P. Chung, 2011, Journal of the National Cancer Institute.

Surveillance in stage I testicular seminoma.

P. Warde, P. Chung, 2001, Urologic oncology.

Management preferences following radical inguinal orchidectomy for Stage I testicular seminoma in Australasia.

P. Warde, H. Sandler, R. Choo, 2002, Australasian radiology.

Computed Tomography in Advanced Ovarian Cancer: An Evaluation of Diagnostic Accuracy

N. Boyd, P. Warde, S. Herman, 1987, The American journal of the medical sciences.

Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors

P. Warde, Philippe Bédard, P. Chung, 2022, European urology open science.

Reply to monitoring of seminoma patients with serum markers

P. Warde, P. Chung, D. Vesprini, 2013, Cancer.

Long term outcome and cost in the management of stage I testicular seminoma.

C. Catton, P. Warde, T. Panzarella, 2000, The Canadian journal of urology.

Stage II testicular seminoma: patterns of recurrence and outcome of treatment.

C. Catton, P. Warde, T. Panzarella, 2004, European urology.

Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance.

P. Warde, Philippe Bédard, A. Hansen, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors for relapse in stage I seminoma managed with surveillance: A validation study.

P. Warde, S. Tyldesley, T. Panzarella, 2010 .

Initial versus recent outcomes with a non–risk adapted surveillance policy in stage I non-seminomatous germ cell tumors (NSGCT)

G. Pond, P. Warde, M. Moore, 2007 .

Simultaneous versus sequential retroperitoneal, thoracic and cervical resection of post chemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis.

P. Warde, P. Bedard, A. Hansen, 2020, Urology.

Appropriate radiation volume for stage IIA/B testicular seminoma.

C. Catton, P. Warde, T. Panzarella, 2003, International journal of radiation oncology, biology, physics.

Testicular cancer: germ cell tumours.

P. Warde, P. Chung, 2016, BMJ clinical evidence.

Chapter 53 – Testicular Cancer

P. Warde, M. Gospodarowicz, D. Hogg, 2012 .

Testicular cancer: seminoma.

P. Warde, P. Chung, 2011, BMJ clinical evidence.

Impact of Granulocyte‐colony Stimulating Factor on Bleomycin‐induced Pneumonitis in Chemotherapy‐treated Germ Cell Tumors

P. Warde, M. Moore, Philippe Bédard, 2017, Clinical genitourinary cancer.

Adjuvant carboplatin in stage I seminoma

P. Warde, M. Gospodarowicz, 2005, The Lancet.

Estimating the Impact of Randomised Control Trial Results on Clinical Practice: Results from a Survey and Modelling Study of Androgen Deprivation Therapy plus Radiotherapy for Locally Advanced Prostate Cancer

Bingshu E. Chen, M. Parmar, M. Sydes, 2016, European urology focus.

Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors.

P. Warde, Philippe Bédard, P. Chung, 2015, The Journal of urology.

Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy.

P. Warde, M. Moore, Philippe Bédard, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomised trial comparing the efficacy of a single radiaton fraction with fractionated radiation therapy in the palliation of skeletal metastases

P. Warde, T. Panzarella, M. McKenzie, 2000 .

Seminar article Surveillance in stage I testicular seminoma

P. Warde, P. Chung, 2006 .

Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.

M. Piérart, L. Collette, R. Mirimanoff, 1997, The New England journal of medicine.

Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 men.

P. Warde, A. Cheung, N. Fleshner, 2010, The Journal of urology.

GU radiation oncologists consensus on bone loss from androgen deprivation.

G. Duncan, P. Warde, T. Pickles, 2006, The Canadian journal of urology.

In Regard to Yerramilli et al’s “Palliative Radiotherapy for Oncologic Emergencies in the Setting of COVID-19: Approaches to Balancing Risks and Benefits”

P. Warde, L. Dawson, E. Hahn, 2020, Advances in Radiation Oncology.

835: Non Risk-Adapted Surveillance Management for Clinical Stage I Nonseminomatous Testis Tumors

P. Warde, Lisa I. Wang, P. Chung, 2007 .

Results of radiotherapy for primary subglottic squamous cell carcinoma.

P. Warde, J. Waldron, B. O'Sullivan, 2002, International journal of radiation oncology, biology, physics.

Progress for prostate cancer?

P. Warde, M. Gospodarowicz, 1997, Nature Reviews Cancer.

POST-CHEMOTHERAPHY RETROPERITONEAL LYMPH NODE DISSECTION FOR TESTICULAR GERM CELL TUMORS: IS SURGERY INDICATED IN ALL AND IS BILATERAL TEMPLATE NECESSARY? PRINCESS MARGARET HOSPITAL EXPERIENCE

P. Warde, P. Chung, M. Jewett, 2009 .

Outcome of curative management of malignant tumours of the parotid gland.

P. Warde, P. Gullane, M. Pintilie, 2001, The Journal of otolaryngology.

Intensity-modulated radiotherapy in the treatment of breast cancer.

P. Warde, G. Bauman, R. B. Rumble, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Optimal Management of High-risk Stage I Nonseminomatous Germ Cell Tumor: Surveillance is the Preferred Option.

P. Warde, A. Hansen, M. Jewett, 2019, European urology focus.

Should surveillance be considered the standard of care in stage I seminoma

C. Catton, P. Warde, T. Panzarella, 2005 .

Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D

I. Tannock, G. Naglie, G. Tomlinson, 2013, Osteoporosis International.

Prostate or bone? Comparing the efficacy of image guidance surrogates for Pelvis & Prostate radiotherapy using accumulated delivered dose.

T. Rosewall, C. Catton, P. Warde, 2019, Journal of medical imaging and radiation sciences.

An analysis of inter-fraction prostate deformation relative to implanted fiducial markers using finite element modelling

K. Brock, A. Nichol, C. Catton, 2004 .

Urethral carcinoma in women: results of treatment with primary radiotherapy.

C. Catton, P. Warde, M. Mclean, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial.

G. Lockwood, P. Warde, J. Waldron, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points.

A R Willan, I. Tannock, T. Smith, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A critical review of the role of definitive radiation therapy in bladder cancer.

P. Warde, M. Gospodarowicz, 1993, Seminars in urology.

Bisphosphonate prescriptions in men with androgen deprivation therapy use.

P. Warde, A. Cheung, L. Paszat, 2014, JAMA.

MP37-08 SERUM MIRNA PREDICTS VIABLE DISEASE POST-CHEMOTHERAPY IN TESTICULAR NON-SEMINOMA GERM CELL TUMOR PATIENTS

P. Warde, L. Looijenga, T. Agthoven, 2018 .

Management and outcome of glottic cancer: a population-based comparison between Ontario, Canada and the SEER areas of the United States. Surveillance, Epidemiology and End Results.

P. Warde, B. O'Sullivan, W. Mackillop, 2000, The Journal of otolaryngology.

Role of epstein‐barr virus in fine‐needle aspirates of metastatic neck nodes in the diagnosis of nasopharyngeal carcinoma

P. Warde, J. Irish, J. Freeman, 1995, Head & neck.

Intensity-modulated radiotherapy in the treatment of lung cancer.

A. Bezjak, P. Warde, A. Hope, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Extended Results and Independent Validation of a Phase 2 Trial of Metastasis Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer.

C. Catton, D. Jaffray, P. Warde, 2022, International journal of radiation oncology, biology, physics.

The results of primary radiation therapy in the management of squamous cell carcinoma of the penis.

P. Warde, M. Mclean, M. Gospodarowicz, 1993, International journal of radiation oncology, biology, physics.

Surveillance for stage I testicular seminoma. a review.

P. Warde, M. Gospodarowicz, A. Bayley, 2001, Urologic oncology.

A phase III randomized trial of intermittent versus continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/ UK Intercontinental Trial CRUKE/01/013).

P. Schellhammer, F. Saad, J. Chin, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cost-effectiveness of intensity-modulated radiotherapy in oropharyngeal cancer.

P. Warde, B. O'Sullivan, S. Huang, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary?

P. Warde, J. Waldron, B. O'Sullivan, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.

C. Catton, P. Warde, G. Bauman, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial comparing two fractionation schedules for patients with localized prostate cancer.

W. J. Morris, P. Warde, M. Brundage, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intermittent androgen suppression for rising PSA level after radiotherapy.

Fred Saad, Emma Hall, Graeme Duncan, 2012, The New England journal of medicine.

Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.

Masoom A Haider, Cynthia Ménard, John Trachtenberg, 2008, International journal of radiation oncology, biology, physics.

A management approach to incompletely excised basal cell carcinomas of skin.

Fei Liu, P. Warde, F. Liu, 1991, International journal of radiation oncology, biology, physics.

Outcome following radiotherapy in verrucous carcinoma of the larynx.

P. Warde, B. O'Sullivan, J. Irish, 1995, International journal of radiation oncology, biology, physics.

Benign parotid adenomas: A review of the princess margaret hospital experience

P. Warde, B. O'Sullivan, A. Davison, 1995, Head & neck.

Glottic cancer in Ontario, Canada and the SEER areas of the United States. Do different management philosophies produce different outcome profiles?

P. Warde, B. O'Sullivan, L. Eapen, 2001, Journal of clinical epidemiology.

The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region.

Fei Liu, P. Warde, J. Waldron, 2001, International journal of radiation oncology, biology, physics.

Management of low-stage testicular seminoma.

P. Warde, N. Fleshner, M. Neill, 2007, The Urologic clinics of North America.

Chapter 55 – Testicular Cancer

P. Warde, P. Chung, P. Bedard, 2016 .

Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.

C. Catton, P. Warde, T. Panzarella, 1997, The Journal of urology.

Stage II Seminoma and Advanced Disease

A. Horwich, P. Warde, 2011 .

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.

S. Fosså, S. Culine, A. Horwich, 2008, European urology.

Spermatocytic seminoma: a review.

P. Warde, M. Gospodarowicz, P. Chung, 2004, European urology.

Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled Analysis

A. Horwich, P. Warde, L. Specht, 2002 .

Stage I seminoma: What should a practicing uro‐oncologist do in 2009?

P. Warde, J. Skliarenko, D. Vesprini, 2009, International journal of urology : official journal of the Japanese Urological Association.

Management of stage II seminoma.

C. Catton, P. Warde, T. Panzarella, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Princess Margaret Hospital Experience in the Management of Stage I and II Seminoma — 1981 to 1991

C. Catton, P. Warde, T. Panzarella, 1994 .

Management of stage I seminomatous testicular cancer: a systematic review.

P. Warde, P. Chung, E. Winquist, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

Evidence‐based guidelines for following stage 1 seminoma

P. Warde, T. Panzarella, P. Chung, 2007, Cancer.

Stage I testicular seminoma: results of adjuvant irradiation and surveillance.

P. Goodman, C. Catton, P. Warde, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evolving concepts in stage I seminoma

P. Warde, M. Gospodarowicz, 2009, BJU international.

Controversies in the management of testicular seminoma.

P. Warde, N. Fleshner, 2002, Seminars in urologic oncology.

A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer

Fei Liu, P. Warde, J. Waldron, 2000, Supportive Care in Cancer.

Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia.

G. Lockwood, P. Warde, J. Waldron, 2005, International journal of radiation oncology, biology, physics.

Clinical integration of machine learning for curative-intent radiation treatment of patients with prostate cancer

C. Catton, P. Warde, T. Purdie, 2021, Nature Medicine.

Pre-treatment risk stratification of prostate cancer patients: A critical review.

P. Warde, M. Brundage, J. Crook, 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate.

C. Catton, P. Warde, M. Mclean, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Optimal treatment of intermediate‐risk prostate carcinoma with radiotherapy

R. Bristow, A. Nichol, P. Warde, 2005, Cancer.

Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT

G. Tomlinson, P. Warde, G. Tomlinson, 2018, BMC Cancer.

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer

Stéphane Supiot, Robert G. Bristow, Jayant S. Goda, 2011, Nature Reviews Clinical Oncology.

Management and outcome differences in supraglottic cancer between Ontario, Canada, and the Surveillance, Epidemiology, and End Results areas of the United States.

P. Warde, B. O'Sullivan, L. Eapen, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A comparison of published head and neck stage groupings in carcinomas of the tonsillar region

W J Mackillop, S F Hall, P. Warde, 2001, Cancer.

Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer.

Pamela Catton, Charles Catton, C. Parker, 2004, International journal of radiation oncology, biology, physics.

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

M. Parmar, M. Sydes, R. Cowan, 2011, The Lancet.

The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer - a systematic review.

C. Catton, P. Warde, M. Brundage, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Omission of Breast Radiotherapy in Low-risk Luminal A Breast Cancer: Impact on Health Care Costs.

Fei Liu, P. Warde, A. Fyles, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Does age influence the behaviour of localized prostate cancer?

P. Warde, M. Gospodarowicz, C. Parker, 2001, BJU international.

Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer.

I. Tannock, G. Naglie, G. Tomlinson, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

C. L. Cutajar, L. Collette, R. Mirimanoff, 2010, The Lancet. Oncology.

Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis.

R. Bristow, C. Catton, D. Jaffray, 2021, European urology.

Daily symptom monitoring commonly leads to treatment modification in older adults receiving treatment for metastatic prostate cancer (mPC).

P. Warde, G. Tomlinson, A. Finelli, 2022, Journal of Clinical Oncology.

Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen‐receptor–targeted therapy for metastatic castration‐resistant prostate cancer

G. Tomlinson, P. Warde, A. Hansen, 2021, Cancer.

Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer

Matthew R. Sydes, Gordana Jovic, Bingshu E. Chen, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Economic Evaluation of a Geriatric Oncology Clinic

Kelvin K. W. Chan, P. Warde, S. Alibhai, 2022, Cancers.

Recurrent prostate cancer following external beam radiotherapy: follow-up strategies and management.

C. Catton, P. Warde, J. Crook, 2003, The Urologic clinics of North America.

Symptom experiences of older adults during treatment for metastatic prostate cancer: A qualitative investigation.

P. Warde, A. Finelli, S. Alibhai, 2022, Journal of geriatric oncology.

A randomized phase III study of neoadjuvant hormonal therapy in patients with localized prostate cancer.

P. Warde, R. Bristow, D. Tsuji, 2006, Clinical genitourinary cancer.

A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy.

R. Bristow, G. Lockwood, A. Nichol, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Synergistic action of image-guided radiotherapy and androgen deprivation therapy

R. Bristow, P. Warde, J. Locke, 2015, Nature Reviews Urology.

Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.

T. Powles, P. Warde, S. Tyldesley, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.

G. Pond, P. Warde, M. Gospodarowicz, 2011, European urology.

A comprehensive systematic review of testicular germ cell tumor surveillance.

P. Warde, M. Jewett, R. Groll, 2007, Critical reviews in oncology/hematology.

Association of Chemotherapy, Enzalutamide, Abiraterone, and Radium 223 With Cognitive Function in Older Men With Metastatic Castration-Resistant Prostate Cancer

P. Warde, G. Tomlinson, A. Hansen, 2021, JAMA network open.

Effects of long‐term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer

I. Tannock, G. Naglie, P. Warde, 2017, Cancer.

Effects of six months of aerobic and resistance training on metabolic markers and bone mineral density in older men on androgen deprivation therapy for prostate cancer.

G. Tomlinson, P. Warde, P. Ritvo, 2020, Journal of geriatric oncology.

Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation model.

C. Catton, P. Warde, A. Zlotta, 2021, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy

G. Tomlinson, P. Warde, G. Tomlinson, 2019, BMC Cancer.

A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy

G. Tomlinson, P. Warde, P. Ritvo, 2015, BMC Cancer.

Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer.

I. Tannock, G. Naglie, G. Tomlinson, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Transitional cell carcinoma of the renal pelvis and ureter: Outcome and patterns of relapse in patients treated with postoperative radiation.

C. Catton, P. Warde, M. Mclean, 1996, Urologic oncology.

Transitional Cell and Ureter Carcinoma of the Renal Pelvis

P. Warde, M. Mclean, T. Panzarella, 1996 .

Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.

T. H. van der Kwast, R. Bristow, P. Warde, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of computed tomography in the T classification of laryngeal carcinoma

P. Warde, B. O'Sullivan, L. Eapen, 2001, Cancer.

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis.

P. Warde, D. Payne, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Does thoracic irradiation improve survival and local control in limited stage small cell carcinoma of the lung - A meta-analysis

P. Warde, D. Payne, 1990 .

Molecular pathology parameters in human nasopharyngeal carcinoma

P. Warde, I. Pataki, Fei-Fei Liu, 2002, Cancer.

Directly Improving the Quality of Radiation Treatment Through Peer Review: A Cross-sectional Analysis of Cancer Centers Across a Provincial Cancer Program.

Margaret Hart, Sophie Foxcroft, P. Warde, 2017, International journal of radiation oncology, biology, physics.

Adjuvant radiotherapy following radical prostatectomy: Genito-Urinary Radiation Oncologists of Canada Consensus Statement.

P. Warde, T. Pickles, G. Morton, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Combination of Hormone Therapy and Radiotherapy in Treatment of Locally Advanced Prostate Cancer—Recent Developments and Update

C. Catton, P. Warde, R. Huang, 2014 .

A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinoma

C. Catton, P. Warde, M. Mclean, 2001, Cancer.

Laryngeal cancer treatment and survival differences across regional cancer centres in Ontario, Canada.

P. Warde, B. O'Sullivan, L. Eapen, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Estimating the costs of intensity-modulated and 3-dimensional conformal radiotherapy in Ontario.

P. Warde, J. Hoch, E. Gutierrez, 2016, Current oncology.

Carcinoma of the maxillary antrum: a retrospective analysis of 110 cases.

P. Warde, J. Waldron, B. O'Sullivan, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Ethmoid sinus cancer: twenty-nine cases managed with primary radiation therapy.

P. Warde, J. Waldron, B. O'Sullivan, 1998, International journal of radiation oncology, biology, physics.

T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control.

R. Bristow, P. Warde, J. Waldron, 1998, International journal of radiation oncology, biology, physics.

Radiotherapy patterns of practice: T1N0 glottic cancer in Ontario, Canada.

P. Warde, B. O'Sullivan, L. Eapen, 2003, Clinics in oncology.

Intensity-modulated radiotherapy in the treatment of head and neck cancer.

P. Warde, B. O'Sullivan, R. B. Rumble, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Contemporary Management of Stage I and II Seminoma

P. Warde, P. Chung, 2013, Current Urology Reports.

Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules.

P. Warde, B. O'Sullivan, L. Eapen, 2006, International journal of radiation oncology, biology, physics.

T1/T2 glottic cancer managed by external beam radiotherapy—The influence of beam energy on local control

P. Warde, J. Waldron, B. O'Sullivan, 1998 .

Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer.

P. Warde, J. Waldron, B. O'Sullivan, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Explaining socioeconomic status effects in laryngeal cancer.

P. Warde, B. O'Sullivan, L. Eapen, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

Best Practice Recommendations for the Retention of Radiotherapy Records.

P. Warde, M. Sharpe, L. Schreiner, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer.

Gary Naglie, Karen E Bremner, George Tomlinson, 2002, Urology.

Levels of sex hormones have limited effect on cognition in older men with or without prostate cancer.

I. Tannock, G. Naglie, P. Warde, 2010, Critical reviews in oncology/hematology.

Pain flare in patients with bone metastases after palliative radiotherapy—a nested randomized control trial

P. Warde, T. Panzarella, T. Panzarella, 2007, Supportive Care in Cancer.

Renal glomerulopathies associated with Hodgkin's disease

P. Warde, B. Cantwell, W. Powderly, 1985, Cancer.

A reliable coding system to define screening prostate-specific antigen tests was developed in a case-control study.

J. Kopec, P. Warde, N. Fleshner, 2005, Journal of clinical epidemiology.

Predictive model for survival in patients with advanced cancer.

I. Tannock, A. Bezjak, P. Warde, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer

D. Osoba, A. Bezjak, P. Warde, 2004, Quality of Life Research.

Comparison of low dose with standard dose abdominal/pelvic multidetector CT in patients with stage 1 testicular cancer under surveillance

M. Haider, P. Warde, K. Jhaveri, 2010, European Radiology.

Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma.

R. Gilbert, P. Warde, J. Waldron, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Loss of p 16 Expression Has Prognostic Significance in Human Nasopharyngeal Carcinoma 1

R. Gilbert, P. Warde, J. Waldron, 2003 .

Durable therapeutic gain despite competing mortality in long-term follow-up of a randomized hyperfractionated radiotherapy trial for locally advanced head and neck cancer

P. Warde, J. Waldron, B. O'Sullivan, 2020, Clinical and translational radiation oncology.

Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer.

Alexandra Rink, Cynthia Ménard, Andrew Bayley, 2016, Brachytherapy.

Carcinoma of the subglottis. Results of initial radical radiation.

P. Warde, T. Keane, A. Harwood, 1987, Archives of otolaryngology--head & neck surgery.

Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer

C. Ménard, C. Catton, P. Warde, 2012, Clinical Cancer Research.

Organisational standards for the delivery of intensity-modulated radiation therapy in Ontario.

K Leszczynski, P. Warde, M. Sharpe, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

1134: Achieving a Consensus Definition for Anatomic Boundaries of the CTV (Prostate Bed): Methods and Observer Reproducibility Using MRI

K. Brock, C. Ménard, M. Haider, 2006 .

Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study

P. Warde, M. Fitch, S. Alibhai, 2016, Supportive Care in Cancer.

of these patients is to maintain this excellent cure rate, while minimising treatment-related complications.

D. Dearnaley, P. Warde, J. Nichols, 2005 .

PMH 9907: Long‐term outcomes of a randomized phase 3 study of short‐term bicalutamide hormone therapy and dose‐escalated external‐beam radiation therapy for localized prostate cancer

R. Bristow, C. Catton, P. Warde, 2016, Cancer.

Recursive partitioning analysis of prognostic factors for survival in patients with advanced cancer.

I. Tannock, A. Bezjak, P. Warde, 2009, International journal of radiation oncology, biology, physics.

Validation of a predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic.

I. Tannock, A. Bezjak, P. Warde, 2009, International journal of radiation oncology, biology, physics.

Use of continuous infusion pumps during radiation treatment.

P. Warde, M. Sharpe, E. Green, 2013, Journal of oncology practice.

Intensity-modulated radiotherapy in the treatment of gynaecological cancers.

B. Yaremko, P. Warde, D. D'Souza, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Impact of Noninvasive Imaging on Increased Incidental Detection of Renal Cell Carcinoma

P. Warde, N. Lightfoot, N. Kreiger, 2000, European Urology.

RECPAM analysis of prognostic factors in patients with Stage III breast cancer

A. Ciampi, P. Warde, C. Erlichman, 1990, Breast Cancer Research and Treatment.

Improvement in total positioning error for lateral prostatic fields using a soft immobilization device.

C. Catton, P. Warde, M. Mclean, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The prostate cancer risk stratification (ProCaRS) project: recursive partitioning risk stratification analysis.

C. Catton, P. Warde, M. Brundage, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor

P. Warde, L. Looijenga, Philippe Bédard, 2018, The Journal of urology.

A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma.

P. Warde, P. Boström, Philippe Bédard, 2018, European urology focus.

The experience of patients with early-stage testicular cancer during the transition from active treatment to follow-up surveillance.

P. Warde, J. Jones, D. Howell, 2016, Urologic oncology.

Management of stage I testicular seminoma.

P. Warde, G. Mok, 2011, Hematology/oncology clinics of North America.

Lymph node growth rate in testicular germ cell tumours: implications for computed tomography surveillance frequency.

P. Warde, T. Panzarella, P. Chung, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Phase 2 trial of guideline-based postoperative image guided intensity modulated radiation therapy for prostate cancer: Toxicity, biochemical, and patient-reported health-related quality-of-life outcomes.

C. Ménard, R. Bristow, C. Catton, 2015, Practical radiation oncology.

Cancer Care Ontario’s Communities of Practice: A Scoping Evaluation

P. Warde, E. Gutierrez, J. Gilbert, 2017 .

Prognostic factors that affect survival outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223.

C. Catton, P. Warde, A. Zlotta, 2020 .

Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma.

C. Ménard, T. Rosewall, C. Catton, 2007, International journal of radiation oncology, biology, physics.

Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell Tumours.

P. Warde, T. Panzarella, M. Gospodarowicz, 2019, European urology oncology.

Is Steroid Receptor Data Useful in Patients with Metastatic Breast Cancer?

A S Detsky, A. Detsky, P. Warde, 1992, The American journal of the medical sciences.

The Use of a Markov Process to Simulate and Assess Follow-up Policies for Patients with Malignant Disease

P. Warde, A. Munro, Padraig R. Warde, 1991, Medical decision making : an international journal of the Society for Medical Decision Making.

Testosterone and erectile function recovery after radiotherapy and long‐term androgen deprivation with luteinizing hormone‐releasing hormone agonists

C. Parker, C. Catton, P. Warde, 2006, BJU international.

High-intensity focused ultrasound for prostate cancer: a systematic review.

G Rodrigues, J. Chin, P. Warde, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

– Prostate Cancer Estimating the Impact of Randomised Control Trial Results on Clinical Practice : Results from a Survey and Modelling Study of Androgen Deprivation Therapy plus Radiotherapy for Locally Advanced Prostate Cancer

Bingshu E. Chen, M. Parmar, M. Sydes, 2016 .

Management of testicular seminoma.

P. Warde, M. Gospodarowicz, M. Milosevic, 1999, Seminars in surgical oncology.

Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences.

N F Boyd, N. Boyd, P. Warde, 1987, Journal of chronic diseases.

A cinematic magnetic resonance imaging study of milk of magnesia laxative and an antiflatulent diet to reduce intrafraction prostate motion.

G. Lockwood, A. Nichol, T. Rosewall, 2010, International journal of radiation oncology, biology, physics.

Screening with prostate specific antigen and metastatic prostate cancer risk: A population-based case-control study.

J. Kopec, P. Warde, N. Fleshner, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The management of locally advanced prostate cancer.

P. Warde, M. Gospodarowicz, D. Hodgson, 1998, Urologic oncology.

Current topics in radiotherapy for genitourinary cancers: Consensus statements of the Genitourinary Radiation Oncologists of Canada.

C. Ménard, P. Warde, A. Berlin, 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

OC-0046 SHORT TERM HORMONE THERAPY AND DOSE ESCALATED RADIATION FOR LOCALIZED PROSTATE CANCER: A RANDOMIZED PHASE III STUDY

C. Catton, P. Warde, M. Gospodarowicz, 2012 .

IMRT utilization in Ontario: qualitative deployment evaluation.

P. Warde, E. Gutierrez, J. Ross, 2014, International journal of health care quality assurance.

The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysis.

P. Warde, A. Zlotta, M. Mamdani, 2016, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.

P. Warde, L. Looijenga, Philippe Bédard, 2020, European urology oncology.

The Clinical Specialist Radiation Therapist (CSRT): A case study exploring the effectiveness of a new advanced practice role in Canada

P. Warde, E. Gutierrez, N. Harnett, 2018, Journal of medical radiation sciences.

Radiation treatment of cervical lymph node metastases from an unknown primary: an analysis of outcome by treatment volume and other prognostic factors.

P. Goodman, P. Warde, B. O'Sullivan, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dosimetric comparison of MR-guided adaptive IMRT versus 3DOF-VMAT for prostate stereotactic radiotherapy

C. Catton, P. Warde, A. Berlin, 2022, Technical innovations & patient support in radiation oncology.

Intermittent Androgen Suppression for Rising PSA Level After Radiotherapy

Joseph L. Chin, Celestia S. Higano, Fred Saad, 2013 .

High-intensity focused ultrasound for prostate cancer: a practice guideline.

J. Chin, P. Warde, G. Rodrigues, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863.

M. Piérart, L. Collette, L. Blank, 2004, European journal of cancer.

Prostate specific antigen levels during radical radiation therapy and the prediction of outcome in localized carcinoma of the prostate.

W Duncan, C. Catton, P. Warde, 1997, Clinical oncology (Royal College of Radiologists (Great Britain)).

The effect of docetaxel, enzalutamide, abiraterone, and radium-223 on cognitive function in older men with metastatic castrate-resistant prostate cancer (mCRPC).

G. Tomlinson, P. Warde, A. Hansen, 2020 .

Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell Tumors

P. Warde, Philippe Bédard, J. Lewin, 2018, JCO Clinical Cancer Informatics.

Prevention and management of osteoporosis in men receiving androgen deprivation therapy: a survey of urologists and radiation oncologists.

P. Warde, A. Cheung, M. Jewett, 2006, Urology.

The influence of delay in the initiation of definitive radiotherapy in carcinoma of the tonsillar region

P. Warde, B. O'Sullivan, W. Mackillop, 1998 .

Cost-effectiveness of intensity-modulated radiotherapy in prostate cancer.

P. Warde, J. Hoch, K. Bremner, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

A comparison of published head and neck stage groupings in laryngeal cancer using data from two countries.

P. Warde, B. O'Sullivan, L. Eapen, 2002, Journal of clinical epidemiology.

Role of Lactate Dehydrogenase in Identifying Relapse for Patients With Stage I Testicular Cancer on Surveillance

A. Bobrowski, P. Warde, J. Sweet, 2022, The Journal of urology.

A Phase 1 Pilot Study of Preoperative Radiation Therapy for Prostate Cancer: Long-Term Toxicity and Oncologic Outcomes.

T. H. van der Kwast, R. Bristow, T. Rosewall, 2019, International journal of radiation oncology, biology, physics.

A phase I trial of pre-operative radiotherapy for prostate cancer: clinical and translational studies.

R. Bristow, P. Warde, L. Klotz, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hospital-level Effects Contribute to Variations in Prostate Cancer Quality of Care.

P. Warde, A. Finelli, R. Hamilton, 2020, European urology oncology.

Prostate cancer: 7. Radiation therapy for localized disease.

C. Catton, P. Warde, M. Gospodarowicz, 1998, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma.

P. Warde, J. Waldron, B. O'Sullivan, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer.

C. Catton, P. Warde, A. Berlin, 2019, Brachytherapy.

The influence of transurethral resection of prostate on prognosis of patients with adenocarcinoma of the prostate treated by radical radiotherapy.

C. Catton, P. Warde, M. Gospodarowicz, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

National cancer strategy 2006: a strategy for cancer control in Ireland: evaluation panel report.

P. Warde, A. Richardson, H. D. Koning, 2015 .

Final Analysis of Intergroup Randomized Phase III Study of Androgen Deprivation Therapy (ADT) ± Radiation Therapy (RT) in Locally Advanced Prostate Cancer (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110; NCT00002633)

Bingshu E. Chen, M. Sydes, P. Warde, 2012 .

Final analysis of intergroup randomized phase III study of androgen deprivation therapy (ADT) plus radiation therapy (RT) in locally advanced prostate cancer (CaP) (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110).

Bingshu E. Chen, M. Parmar, M. Sydes, 2012 .

7007 Three years of adjuvant androgen deprivation with goserelin in patients with locally advanced prostate cancer treated with radiotherapy: Results at 10 years of EORTC trial 22863

M. Piérart, L. Collette, R. Mirimanoff, 2009 .

Sex or survival

G. Tomlinson, A. Bezjak, P. Warde, 2010, Cancer.

The role of hemoglobin concentration in clinically localized prostate cancer treated with radical radiotherapy +/- neoadjuvant androgen deprivation.

D. Dearnaley, A. Horwich, R. Huddart, 2004, International journal of radiation oncology, biology, physics.

Improving radiotherapy utilization rates in Ontario.

P. Warde, E. Gutierrez, L. Favell, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The effect of bowel preparation regime on interfraction rectal filling variation during image guided radiotherapy for prostate cancer

R. Bristow, T. Rosewall, C. Catton, 2017, Radiation oncology.

The Role of IMRT in Central Nervous System Cancer

P. Warde, N. Laperriere, 2013 .

The Role of IMRT in Thyroid Cancers

P. Warde, J. Brierley, 2013 .

Evidence-Based Series 21-3-10-EDUCATION AND INFORMATION 2013 The Role of IMRT in Gastrointestinal Cancers

P. Warde, 2013 .

Evidence-Based Series 21-3-5- EDUCATION AND INFORMATION 2013 The Role of IMRT in Lung Cancer

A. Bezjak, P. Warde, A. Hope, 2013 .

High-intensity Focused Ultrasound for Prostate Cancer

J. Chin, P. Warde, G. Rodrigues, 2012 .

[18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial

R. Bristow, C. Catton, D. Jaffray, 2020, BMJ Open.

A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancer.

R. Gilbert, P. Warde, J. Waldron, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

153 A prospective randomized trial of hyperfractionated versus conventional once daily radiation for advanced squamous cell carcinomas of the larynx and pharynx

P. Warde, J. Waldron, B. O'Sullivan, 1996 .

107A prospective randomized trial of hyperfractionated versus conventional once daily radiation for advanced squamous cell carcinomas of the larynx and pharynx

P. Warde, J. Waldron, B. O'Sullivan, 1996 .

Cost of Bladder Cancer Care: A Single-center Comparison of Radical Cystectomy and Trimodal Therapy

C. Catton, P. Warde, A. Zlotta, 2023, Urology practice.

C. Ménard, R. Bristow, C. Catton, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Characterization of relapse in patients with clinical stage I (CSI) nonseminoma (NS-TC) managed with active surveillance (AS): A large multicenter study.

P. Warde, M. Moore, P. Bedard, 2013 .

Pathological predictors for site of local recurrence after radiotherapy for prostate cancer.

A. Evans, C. Ménard, M. Haider, 2012, International journal of radiation oncology, biology, physics.

Long‐term impact of androgen‐deprivation therapy on physical function and quality of life

I. Tannock, G. Naglie, G. Tomlinson, 2015, Cancer.

National survey addressing the information needs of primary care physicians: Side effect management of patients on androgen deprivation therapy.

P. Warde, N. Fleshner, J. Locke, 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

The prostate cancer risk stratification project: database construction and risk stratification outcome analysis.

C. Catton, P. Warde, M. Brundage, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer

David A Jaffray, Masoom A Haider, Cynthia Ménard, 2013, Journal of magnetic resonance imaging : JMRI.

Correction: Image guided dose escalated prostate radiotherapy: still room to improve

C. Ménard, T. Rosewall, C. Catton, 2009, Radiation Oncology (London, England).

Low and intermediate risk prostate cancer-- role of hormonal therapy with external beam radiation therapy.

P. Warde, R. Bristow, Jarad Martin, 2006, The Canadian journal of urology.

In response to Dr. Beitler

P. Warde, J. Waldron, D. Payne, 2002 .

Long-Term Outcomes of a Phase 2 Trial of Moderate Hypofractionated Image Guided Intensity Modulated Radiation Therapy (IG-IMRT) for Localized Prostate Cancer

C. Ménard, R. Bristow, C. Catton, 2016 .

Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac

C. Catton, P. Warde, A. Berlin, 2022, Technical innovations & patient support in radiation oncology.

Major 30‐day complications after radical radiotherapy

P. Warde, S. Alibhai, M. Leach, 2009, Cancer.

In response to Drs. Momm and Lutterbach

P. Warde, J. Waldron, B. O'Sullivan, 2005 .

Computed tomography in advanced ovarian cancer. Inter- and intraobserver reliability.

N. Boyd, P. Warde, S. Herman, 1986, Investigative radiology.

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

M. Parmar, M. Sydes, R. Cowan, 2011, Lancet.

Long term results of immediate adjuvant hormonal therapy with goserelin in patients with locally advanced prostate cancer treated with radiotherapy — A phase III EORTC study

M. Piérart, L. Collette, R. Mirimanoff, 1999 .

5 Long term results of immediate adjuvant hormonal therapy with goserelin in patients with locally advanced prostate cancer treated with radiotherapy. A phase III EORTC study

M. Piérart, L. Collette, R. Mirimanoff, 1999 .

Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell Tumors

P. Warde, Philippe Bédard, J. Lewin, 2018, JCO clinical cancer informatics.

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

M. Parmar, M. Sydes, R. Cowan, 2011, Lancet.

Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours

Benjamin Haibe-Kains, N. Winegarden, P. Warde, 2018, BJU international.

The association between institution at orchiectomy and outcomes on active surveillance for clinical stage I germ cell tumours.

P. Warde, Philippe Bédard, P. Chung, 2016, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Ten Year Results of Long Term Adjuvant Androgen Deprivation with Goserelin in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy: A Phase III EORTC Study

M. Piérart, L. Collette, R. Mirimanoff, 2008 .

Defining advanced practice in radiation therapy: A feasibility assessment of a new healthcare provider role in Ontario, Canada.

P. Warde, E. Gutierrez, N. Harnett, 2019, Radiography.

Excellent outcomes in bilateral testicular germ cell tumors over four decades.

P. Warde, P. Bedard, A. Hansen, 2019, Journal of Clinical Oncology.

Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.

P. Warde, P. Goodwin, J. Pater, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The importance of local control in high-risk locally advanced prostate cancer.

P. Warde, S. Sridharan, 2012, Current oncology.

Intermittent androgen suppression for rising PSA level after radiotherapy.

F. Saad, J. Chin, G. Duncan, 2012, New England Journal of Medicine.

Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response.

C. Ménard, C. Parker, C. Catton, 2007, Cancer research.

Re: Vikram, B., The PSA conundrum. [Radiother Oncol, 2004. 71(1): p. 1-2].

R. Bristow, P. Warde, M. Gospodarowicz, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer

C. Ménard, C. Catton, P. Warde, 2012, Clinical Cancer Research.

Omission of Breast Radiotherapy in Low-risk Luminal A Breast Cancer: Impact on Health Care Costs.

Fei Liu, P. Warde, A. Fyles, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Management of localized seminoma, stage I-II: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.

P. Warde, S. Fosså, Axel Heidenreich, 2011, Urology.

Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial.

G. Lockwood, P. Warde, J. Waldron, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.

G. Pond, P. Warde, M. Gospodarowicz, 2011, European urology.

Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer.

P. Warde, A. Berlin, E. Saibishkumar, 2022, Brachytherapy.

Clinical and biochemical outcome of conventional dose radiotherapy for localized prostate cancer.

C. Catton, P. Warde, M. Mclean, 2002, The Canadian journal of urology.

Intermittent androgen suppression for rising PSA level after radiotherapy.

F. Saad, J. Chin, G. Duncan, 2012, The New England journal of medicine.

Improving the Quality of Radiation Treatment for Patients in Ontario: Increasing Peer Review Activities on a Jurisdictional Level Using a Change Management Approach.

P. Warde, M. Sharpe, M. Brundage, 2016, Journal of oncology practice.

A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancer.

R. Gilbert, P. Warde, J. Waldron, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

RadiotherapyRadiotherapy: practical applications and clinical aspects

P. Warde, 2008 .

Real-World Practice Patterns and Predictors of Continuous versus Intermittent Androgen Deprivation Therapy Use for Prostate Cancer in Older Men

P. Warde, N. Fleshner, S. Sridhar, 2021, The Journal of urology.

Home-based versus supervised group exercise in men with prostate cancer on androgen deprivation therapy: A randomized controlled trial and economic analysis.

P. Warde, G. Tomlinson, S. Alibhai, 2023, Journal of geriatric oncology.